ArticleClinics and practice2023

Infection Risk, Mortality, and Hypogammaglobulinemia Prevalence and Associated Factors in Adults Treated with Rituximab: A Tertiary Care Center Experience.

Moustafa S Alhamadh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.